Low dosage and long treatment duration of β-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae

JAMA

Volumn 279, Issue 5, 1998, Pages 365-370

  Guillemot, D ^a   Carbon, C ^a   Balkau, B ^a   Geslin, P ^a   Lecoeur, H ^a   Vauzelle Kervroedan, F ^a   Bouvenot, G ^a   Eschwege, E ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN G SODIUM; PENICILLIN V;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; DRUG USE; FRANCE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; PHARYNGITIS; PRIORITY JOURNAL; RISK ASSESSMENT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0032481410     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.5.365     Document Type: Article

References (45)